These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38043734)

  • 1. Diagnosis of transthyretin amyloidosis in patients with established cardiomyopathy.
    Martín-Álvarez E; Larrañaga-Moreira JM; Barge-Caballero G; Souto-Caínzos B; Crepo-Leiro MG; Barriales-Villa R
    Rev Esp Cardiol (Engl Ed); 2024 Apr; 77(4):347-349. PubMed ID: 38043734
    [No Abstract]   [Full Text] [Related]  

  • 2. Extracellular Volume Detects Amyloidotic Cardiomyopathy and Correlates With Neurological Impairment in Transthyretin-familial Amyloidosis.
    Gallego-Delgado M; González-López E; Muñoz-Beamud F; Buades J; Galán L; Muñoz-Blanco JL; Sánchez-González J; Ibáñez B; Mirelis JG; García-Pavía P
    Rev Esp Cardiol (Engl Ed); 2016 Oct; 69(10):923-930. PubMed ID: 27291669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice.
    Witteles RM; Bokhari S; Damy T; Elliott PM; Falk RH; Fine NM; Gospodinova M; Obici L; Rapezzi C; Garcia-Pavia P
    JACC Heart Fail; 2019 Aug; 7(8):709-716. PubMed ID: 31302046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac Amyloidosis in a Child Presenting with Syncope: The First Reported Case and a Diagnostic Dilemma.
    Torpoco Rivera DM; Williams CT; Karpawich PP
    Pediatr Cardiol; 2022 Mar; 43(3):700-703. PubMed ID: 34783874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transthyretin Glu54Leu - an unknown mutation within the Swedish population associated with amyloid cardiomyopathy and a unique fibril type.
    Hellman U; Lång K; Ihse E; Jonasson J; Olsson M; Lundgren HE; Pilebro B; Westermark P; Wixner J; Anan I
    Scand J Clin Lab Invest; 2019 Oct; 79(6):372-376. PubMed ID: 31169435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology.
    Skrahina V; Grittner U; Beetz C; Skripuletz T; Juenemann M; Krämer HH; Hahn K; Rieth A; Schaechinger V; Patten M; Tanislav C; Achenbach S; Assmus B; Knebel F; Gingele S; Skrahin A; Hartkamp J; Förster TM; Roesner S; Pereira C; Rolfs A
    Ann Med; 2021 Dec; 53(1):1787-1796. PubMed ID: 34658264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case With Transthyretin Amyloid Cardiomyopathy Complicated With Rapidly Progressive Aortic Stenosis Possibly Caused by Amyloid Deposition in the Aortic Valve.
    Fujimoto T; Yamano T; Miyagawa-Hayashino A; Naiki H; Ueda M; Tasaki M; Yamano M; Zen K; Numata S; Matoba S
    Circ Cardiovasc Imaging; 2021 Nov; 14(11):e013357. PubMed ID: 34727706
    [No Abstract]   [Full Text] [Related]  

  • 8. Unmasking Early Wild-Type Transthyretin Amyloidosis Cardiomyopathy in a Patient With Refractory Atrial Fibrillation and Unremarkable Cardiac Imaging.
    Varedi D; Kovacsovics T; Downs Kelly E; Abraham J; Cowley J; Barrell K; Revelo MP; Stehlik J; Drakos S; Marrouche N; Wilson B; Swanson EA; Fang J; Nativi-Nicolau J
    Circ Heart Fail; 2018 Jul; 11(7):e004812. PubMed ID: 29921704
    [No Abstract]   [Full Text] [Related]  

  • 9. Wild-Type Transthyretin Cardiac Amyloidosis Is Associated with Increased Antecedent Physical Activity.
    Lee YZJ; Fajardo J; Brown E; D'Adamo CR; Judge DP
    J Cardiovasc Transl Res; 2022 Aug; 15(4):689-691. PubMed ID: 35083733
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging.
    Dahlem K; Michels G; Kobe C; Bunck AC; Ten Freyhaus H; Pfister R
    Clin Res Cardiol; 2017 Jun; 106(6):471-473. PubMed ID: 28303323
    [No Abstract]   [Full Text] [Related]  

  • 11. Transforming ATTR cardiac amyloidosis into a chronic disease: The enormous potential of quantitative SPECT to improve diagnosis, prognosis, and monitoring of disease progression.
    Ayers MP; Peruri AV; Bourque JM
    J Nucl Cardiol; 2021 Oct; 28(5):1846-1850. PubMed ID: 33851351
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis.
    Gertz MA; Benson MD; Dyck PJ; Grogan M; Coelho T; Cruz M; Berk JL; Plante-Bordeneuve V; Schmidt HHJ; Merlini G
    J Am Coll Cardiol; 2015 Dec; 66(21):2451-2466. PubMed ID: 26610878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transthyretin Cardiac Amyloidosis Disguised as Light Chain Amyloidosis or Multiple Myeloma?
    Stein AP; Matthia EL; Petty SA; Stewart B; Vilaro JR; Al-Ani MAZ; Ahmed MM; Aranda JM; Hiemenz JW; Parker AM
    Am J Cardiol; 2024 Jan; 210():85-92. PubMed ID: 37852567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High 99mTc-DPD myocardial uptake in a patient with apolipoprotein AI-related amyloidotic cardiomyopathy.
    Quarta CC; Obici L; Guidalotti PL; Pieroni M; Longhi S; Perlini S; Verga L; Merlini G; Rapezzi C
    Amyloid; 2013 Mar; 20(1):48-51. PubMed ID: 23231421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trajectory of left ventricular geometry and diastolic dysfunction in hereditary transthyretin cardiac amyloidosis.
    Akatsuka T; Fujimoto N; Ishiyama M; Nakamori S; Imanaka-Yoshida K; Dohi K
    ESC Heart Fail; 2021 Aug; 8(4):3422-3426. PubMed ID: 34145794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of transthyretin amyloid cardiomyopathy in patients admitted for acute heart failure.
    Spaccavento A; Rodríguez MDR; Meretta A; Elissamburu P; Carvelli V; Gobbo M; Rosa D; Masoli O; Conde D; Costabel JP
    Curr Probl Cardiol; 2024 Mar; 49(3):102385. PubMed ID: 38184135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring treatment response to tafamidis by serial native T1 and extracellular volume in transthyretin amyloid cardiomyopathy.
    Shintani Y; Okada A; Morita Y; Hamatani Y; Amano M; Takahama H; Amaki M; Hasegawa T; Ohta-Ogo K; Kanzaki H; Ishibashi-Ueda H; Yasuda S; Shimazaki C; Yoshinaga T; Yazaki M; Sekijima Y; Izumi C
    ESC Heart Fail; 2019 Feb; 6(1):232-236. PubMed ID: 30478886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and prognostic implications of orthopedic ligament disorders in patients with wild-type transthyretin amyloidosis cardiomyopathy.
    Malik GMA; Samiullah FNU; Khenhrani RR
    J Cardiol; 2024 Feb; 83(2):138. PubMed ID: 37783269
    [No Abstract]   [Full Text] [Related]  

  • 19. Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.
    Rigopoulos AG; Ali M; Abate E; Torky AR; Matiakis M; Mammadov M; Melnyk H; Vogt A; de Vecchis R; Bigalke B; Wohlgemuth W; Mavrogeni S; Noutsias M
    Heart Fail Rev; 2019 Jul; 24(4):521-533. PubMed ID: 30790171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy.
    Paton DM
    Drugs Today (Barc); 2019 Dec; 55(12):727-734. PubMed ID: 31942875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.